Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab Concentration in Breast Milk of Lactating Women With Relapsing Multiple Sclerosis
NCT06444113Phase 4Active, not recruiting
- Sponsor
- Novartis
- Start
- Nov 2024
- Primary completion
- Feb 2026
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 4 trial of ofatumumab in multiple sclerosis (MS), sponsored by Novartis. Started Nov 2024; status: active, not recruiting.
02
Drugs
ofatumumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT06444113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06444113.